HCID 59408775, 화합물 → HCID 25000776, 화합물

HRID 1188106노트

반응식

HRID 1188106 반응식
[CH2:1]([NH:8][C:9]1[S:10][C:11]([C:14]([NH:16][C:17]2[S:18][C:19]([C:22]3[CH:27]=[CH:26][C:25]([CH3:28])=[CH:24][CH:23]=3)=[CH:20][N:21]=2)=O)=[CH:12][N:13]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>C1COCC1>[CH2:1]([NH:8][C:9]1[S:10][C:11]([CH2:14][NH:16][C:17]2[S:18][C:19]([C:22]3[CH:23]=[CH:24][C:25]([CH3:28])=[CH:26][CH:27]=3)=[CH:20][N:21]=2)=[CH:12][N:13]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

참가 물질

3

실험 절차

BMS (0.2 mL, 2.1 mmol) was added to a solution of 2-(benzylamino)-N-(5-p-tolylthiazol-2-yl)thiazole-5-carboxamide (170 mg, 0.42 mmol) in THF (6 mL) at RT. The resulting solution was stirred at reflux overnight. The reaction was then quenched with MeOH (2 mL) and 1N HCl was added until the pH reached 2. After stirring the reaction mixture at reflux temperature for 12 hrs, the organic solvents were evaporated and the aqueous solution was neutralized with 1N NaOH, extracted with CHCl3, dried with Na2SO4 and concentrated. The crude product was purified by column (AcOEt), yielding N-benzyl-5-((5-p-tolylthiazol-2-ylamino)methyl)thiazol-2-amine (30 mg, 18%).

후처리

  1. temperatureat reflux overnight
  2. customThe reaction was then quenched with MeOH (2 mL) and 1N HCl
  3. additionwas added until the pH
  4. stirringAfter stirring the reaction mixture
  5. temperatureat reflux temperature for 12 hrs
  6. customthe organic solvents were evaporated
  7. extractionextracted with CHCl3
  8. dry with materialdried with Na2SO4
  9. concentrationconcentrated
  10. customThe crude product was purified by column (AcOEt)

출처 및 근거

ORD 기록
ord-1f32a05b3d224cd097b1b6dff496d82c
출처 데이터셋
uspto-grants-2014_03
특허 번호
US08673940B2

반응 노트

불러오는 중…